Scientists have developed an innovative at-home test designed to predict an individual's risk of developing Alzheimer's disease. The novel method combines a simple finger-prick blood test, which can be posted to labs, with an online cognitive assessment, both conveniently conducted from home. This home-based screening aims to identify individuals experiencing early memory and cognitive issues, allowing those at highest risk to be prioritised for further diagnostic tests, treatment, and support.
How the Test Works
The finger-prick blood tests look for specific biomarkers, p-tau217 and GFAP, which have been linked to Alzheimer's disease and broader brain decline respectively. The online cognitive assessment evaluates memory and thinking skills. Together, they provide a comprehensive risk profile that can be analysed remotely.
Potential Impact on Dementia Care
Experts believe this approach could revolutionise dementia diagnosis by offering a scalable and cost-effective way to screen people. Currently, many individuals with early symptoms face long waits for specialist appointments and invasive tests. This at-home method could streamline the process, enabling earlier intervention and support.
However, researchers caution that larger and more diverse studies are needed to confirm its effectiveness in everyday healthcare settings. The current study involved a limited sample, and further validation is required before widespread adoption.
Early Signs of Alzheimer's
- Memory loss that disrupts daily life
- Challenges in planning or solving problems
- Difficulty completing familiar tasks
- Confusion with time or place
- Trouble understanding visual images and spatial relationships
If you or a loved one experience these symptoms, consulting a healthcare professional is recommended. The new test could become a valuable tool for early detection, but it is not yet available for public use.
